Fludarabine as therapy in chronic lymphocytic leukemia (CLL) in patients over 70 years.

被引：0
|
作者：
Conte, GF [1 ]
Aravena, PC [1 ]
Fardella, PD [1 ]
Alfaro, JI [1 ]
Araos, DM [1 ]
Flores, CIDA [1 ]
González, NA [1 ]
机构：
[1] Univ Chile, Clin Hosp, Santiago, Chile
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5009
引用
收藏
页码：363B / 363B
页数：1
相关论文
共 50 条
  • [1] FLUDARABINE THERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    KEATING, MJ
    KANTARJIAN, H
    TALPAZ, M
    REDMAN, J
    MCCREDIE, KB
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (5-6): : 461 - 466
  • [2] Fludarabine (FAMP) and mitoxantrone therapy in chronic lymphocytic leukemia (CLL).
    OBrien, S
    Kantarjian, H
    Beran, M
    Robertson, IE
    Freireich, E
    Kornblau, S
    Koller, C
    Estey, E
    Lerner, S
    Keating, M
    BLOOD, 1996, 88 (10) : 2341 - 2341
  • [3] Fludarabine (FAMP) and cyclophosphamide (CTX) therapy in chronic lymphocytic leukemia (CLL)
    OBrien, S
    Kantarjian, H
    Beran, M
    Lerner, S
    Gilbreath, J
    Keating, MJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 453 - 453
  • [4] Fludarabine (FAMP) and cyclophosphamide (CTX) therapy in chronic lymphocytic leukemia (CLL).
    OBrien, S
    Kantarjian, H
    Beran, M
    Freireich, E
    Komblau, S
    Koller, C
    Lerner, S
    Gilbreath, J
    Keating, M
    BLOOD, 1996, 88 (10) : 1910 - 1910
  • [5] FLUDARABINE PLUS THALIDOMIDE AS FRONTLINE THERAPY FOR NEWLY DIAGNOSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Ailawadhi, S.
    Miller, K. C.
    Depaolo, D.
    Whitworth, A.
    Brady, W.
    Czuczman, M.
    Bernstein, Z. P.
    Hernandez-Ilizaliturri, F.
    Padmanabhan, S.
    Chanan-Khan, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 34 - 34
  • [6] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [7] Lumiliximab with fludarabine, cyclophosphamide, and rituximab (FCR) for patients with relapsed chronic lymphocytic leukemia (CLL).
    O'Brien, S.
    Byrd, J. C.
    Kipps, T. J.
    Forero-Torres, A.
    Flinn, I. W.
    Wynne, D. I.
    Molina, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 360S - 360S
  • [8] Fludarabine (FAMP) and cyclophosphamide (CTX) combination in chronic lymphocytic leukemia (CLL).
    Gonzalez, H
    Cazin, B
    Dighiero, G
    Merle-Béral, H
    Vernant, JP
    Binet, JL
    Maloum, K
    BLOOD, 1998, 92 (10) : 277B - 277B
  • [9] GENETIC DETERMINANTS OF FLUDARABINE-RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Messina, M.
    Del Giudice, I.
    Rossi, D.
    Chiaretti, S.
    Rasi, S.
    Spina, V.
    Khiabanian, H.
    Holmes, A.
    Marinelli, M.
    Fabbri, G.
    Rossi, A.
    Guarini, A.
    Pasqualucci, L.
    Rabadan, R.
    Dalla-Favera, R.
    Gaidano, G.
    Foa, R.
    HAEMATOLOGICA, 2013, 98 : 239 - 239
  • [10] Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
    Erin M. Pettijohn
    Shuo Ma
    Current Hematologic Malignancy Reports, 2017, 12 : 20 - 28
12345